title: Why Pfizer's Headwinds May Already Be In The Price
source: SeekingAlpha
date: 2025-10-24
url: https://finnhub.io/api/news?id=34268297a9da89cd4aa1ae6b900ca37bd3b9ce594c7e1f7b7eb046c5a729e298
Pfizer (PFE) offers potential 20-30% upside despite revenue risks. Explore its valuation, pipeline prospects, and dividend stability. Click here to read.
